SCHEMBL2196274

SCHEMBL2196274

Cc1cc(Cl)ccc1Nc1ccc(C(=O)c2cc(O)ccc2F)c(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 11/20 0.59
MAPK12 P53778 11/20 0.59
MAPK11 Q15759 11/20 0.59
MAPK14 Q16539 11/20 0.59
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NOX1 Q9Y5S8 2/20 0.43
CNR2 P34972 1/20 0.41
RAPGEF4 Q8WZA2 1/20 0.40
MEN1 O00255 2/20 0.39
LMNA P02545 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
AVPR2 P30518 1/20 0.39
OXTR P30559 1/20 0.39
AVPR1A P37288 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198903 0.92 MAPK14 (0.71) MAPK13MAPK12MAPK11MAPK14NOX1
SCHEMBL5988678 0.84 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2198443 0.84 MAPK14 (0.56) MAPK13MAPK12MAPK11MAPK14CNR2
SCHEMBL2199363 0.84 MAPK14 (0.56) MAPK13MAPK12MAPK11MAPK14
SCHEMBL2201685 0.81 MAPK14 (0.52) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL1907242 0.81 MAPK14 (0.81) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2199519 0.81 MAPK13 (0.51) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL2196276 0.81 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2200571 0.80 MAPK13 (0.50) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2199484 0.79 MAPK14 (0.49) MAPK13MAPK12MAPK11MAPK14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
CN-1826310-B Novel aminobenzophenone compounds LEO PHARMA AS 2010-07-21 CN disclosed
CN-1826310-A Novel aminobenzophenone compounds LEO PHARMA AS (DK) 2006-08-30 CN disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.